Tnya vs tsha which stock to buy


Aime
Tenaya Therapeutics (TNYA) appears to be the stronger investment option compared to Taysha Gene Therapies (TSHA) based on the following analysis:
- Financial Ratios: Tenaya Therapeutics has a higher Price-to-Earnings (P/E) ratio of 17.33 compared to Taysha Gene Therapies' P/E ratio of 6.21. A higher P/E ratio can indicate that investors are willing to pay more for a stock, which may suggest growth prospects.
- Price Target and Consensus Rating: Tenaya Therapeutics has a higher average price target of $17.33, with a consensus rating of "Strong Buy"1. In contrast, Taysha Gene Therapies has a lower average price target of $6.2, also rated as "Strong Buy"1. The higher price target and consensus for TNYA could indicate greater confidence in its future performance.
- Recent Performance: Tenaya Therapeutics saw a 20.39% increase in its stock price to $3.012, which is a positive sign. Taysha Gene Therapies rose by 27.56% to $2.083, showing significant gains but starting from a lower base.
TSHA, TNYA5-Day Moving Average
单位
- Fund Flow: Tenaya Therapeutics had a net fund outflow of $254,857.52, which is less than Taysha Gene Therapies' outflow of $1.25 million4. This could suggest less intense selling pressure on TNYA.
TSHA, TNYA Net Fund Flow
- Earnings Estimates: Earnings estimates for Tenaya Therapeutics have been revised upwards, with the latest estimate showing a fiscal year 2024 earnings per share (EPS) of ($1.35), compared to the previous estimate of ($1.46)5. This indicates potential improvement in financial performance.
- Analyst Ratings: Several analysts have given TNYA a "Buy" rating, with price targets ranging from $16.00 to $18.0065 The consensus price target of $14.75 indicates potential upside from the current price.
- Market Sentiment: Tenaya Therapeutics has received positive research reports, with analysts setting a higher price target and maintaining a "Buy" rating65 This suggests a positive market sentiment towards the stock.
While both stocks have been rated as "Strong Buy," Tenaya Therapeutics appears to have a more favorable outlook based on the discussed factors. However, it's important to consider your investment goals, risk tolerance, and consult with a financial advisor before making any investment decisions.
Source:
1.
TNYA, TSHA Average Price Target, Consensus Rating
more
less
Continue this conversation 

Explore
Screener
Analysis
Learn
News
Wiki